Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2026-01-05 @ 6:10 PM
Study NCT ID:
NCT01245166
Status:
UNKNOWN
Last Update Posted:
2010-11-22
First Post:
2010-11-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus
Sponsor:
Lotus Pharmaceutical
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2011-12
Completion Date Type:
ESTIMATED
First Submit Date:
2010-11-19
First Submit QC Date:
None
Study First Post Date:
2010-11-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-11-19
Last Update Post Date:
2010-11-22
Last Update Post Date Type:
ESTIMATED